Skip to main content
. 2021 Apr 10;113(10):1379–1385. doi: 10.1093/jnci/djab076

Figure 1.

Figure 1.

Cumulative incidence of primary cutaneous melanoma in (A) all participants, (B) male participants, and (C) female participants. Competing risks model of the cumulative incidence of primary cutaneous melanoma in the ASPirin in Reducing Events in the Elderly cohort, stratified by a polygenic risk score (PRS) for cutaneous melanoma, categorized into low-risk (0%-20%), medium-risk (20%-80%), and high-risk (80%-100%) groups.